Ajanta Pharma Ltd.
3,278.80-36.2 (-1.09%)
8 Jul, 12:00 AM
Annual Reports and Financial Documents
Ajanta Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
Corporate Announcements and Regulatory Filings
Ajanta Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
- Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 08, 2026 for Aayush Agrawal, ....
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Aayush Agrawal Trust ....
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 01, 2026 for Ravi Agrawal, trustee ....
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 26, 2026 for Ravi Agrawal, trustee ....
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 19, 2026 for Ravi Agrawal, trustee ....
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 15, 2026 for Aayush Agrawal, trustee ....
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ravi Agrawal, Trustee Ravi Agrawal Trust
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 08, 2026 for Aayush Agrawal, trustee ....
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 08, 2026 for Gabs Investments Pvt Ltd
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 02, 2026 for Ravi Agrawal, trustee ....
Frequently Asked Questions
Where can I download the annual report of Ajanta Pharma Ltd.?
Annual reports of Ajanta Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Ajanta Pharma Ltd.?
Quarterly earnings results and presentations of Ajanta Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Ajanta Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Ajanta Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Ajanta Pharma Ltd.?
Investor presentations and annual day presentations of Ajanta Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Ajanta Pharma Ltd.?
Corporate announcements and regulatory filings of Ajanta Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Ajanta Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Ajanta Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Ajanta Pharma Ltd.?
The ISIN (International Securities Identification Number) of Ajanta Pharma Ltd. is INE031B01049. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Ajanta Pharma Ltd. listed?
Ajanta Pharma Ltd. is listed on NSE and BSE. The NSE symbol is AJANTPHARM and the BSE code is -.
Where can I find the shareholding pattern of Ajanta Pharma Ltd.?
The quarterly shareholding pattern of Ajanta Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Ajanta Pharma Ltd. on Sharpely?
Share price data for Ajanta Pharma Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.